ISSN:
2181-3906
2025
In e na ional scien i ic jou nal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 11 / UIF:8.2 / MODERNSCIENCE.UZ
723
THE BIOLOGICAL MECHANISMS UNDERLYING THE DEVELOPMENT OF
DIABETIC NEPHROPATHY
Tulaye a D.M.
S uden o he Facul y o Medical Biology, G oup 23-04.
olaye adilba @gmail.com
Jo‘ aye M.B.
Scien i ic Supe iso .
Tashken S a e Medical Uni e si y, Tashken , Uzbekis an.
h ps://doi.o g/10.5281/zenodo.17720253
Abs ac . Diabe ic neph opa hy (DN) ep esen s one o he mos se e e and p og essi e
mic o ascula complica ions o diabe es melli us, ul ima ely leading o ch onic kidney disease
and end-s age enal ailu e i le un ea ed. Despi e decades o esea ch, he biological
mechanisms unde lying i s ini ia ion and p og ession emain complex and mul i ac o ial. This
pape p o ides a comp ehensi e analysis o he cellula and molecula pa hways ha con ibu e
o DN de elopmen , ocusing on hype glycemia-induced me abolic dis u bances, oxida i e
s ess, ch onic in lamma ion, glome ula hemodynamic abno mali ies, and epigene ic
modi ica ions. Pe sis en hype glycemia igge s excessi e p oduc ion o ad anced glyca ion end
p oduc s (AGEs), ac i a ion o he polyol and hexosamine pa hways, and p o ein kinase C (PKC)
o e exp ession, all o which syne gis ically damage glome ula and ubula s uc u es.
Oxida i e s ess, d i en by mi ochond ial dys unc ion and NADPH oxidase ac i a ion,
u he ampli ies enal inju y by p omo ing endo helial dys unc ion, mesangial expansion, and
podocy e apop osis. Concu en ly, p o-in lamma o y cy okines—including IL-1β, IL-6, TNF-α,
and MCP-1—ac i a e NF-κB–media ed pa hways, c ea ing a sel -pe pe ua ing cycle o
in lamma ion and ib osis wi hin enal issues. Al e ed in aglome ula p essu e caused by
dys egula ion o he enin–angio ensin–aldos e one sys em (RAAS) accele a es basemen
memb ane hickening and glome uloscle osis, while loss o podocy e in eg i y con ibu es o
p o einu ia, he hallma k o DN. Epigene ic modi ica ions such as DNA me hyla ion and his one
ace yla ion ha e ecen ly been iden i ied as key d i e s o “me abolic memo y,” explaining why
enal damage con inues e en a e glycemic con ol is achie ed. By in eg a ing con empo a y
(2020–2024) esea ch indings, his pape delinea es DN as an in e play be ween me abolic,
hemodynamic, in lamma o y, and epigene ic ac o s a he han a single-pa hway disease.
Unde s anding hese in e connec ed mechanisms is essen ial o de eloping a ge ed
he apies capable o p e en ing, slowing, o e e sing diabe ic kidney damage.
Keywo ds: Diabe ic neph opa hy; diabe es melli us; ch onic kidney disease;
hype glycemia; oxida i e s ess; ad anced glyca ion end p oduc s (AGEs); p o ein kinase C
(PKC) pa hway; mi ochond ial dys unc ion; in lamma ion; NF-κB signaling; enin–angio ensin–
aldos e one sys em (RAAS); podocy e inju y; glome uloscle osis; me abolic memo y; epigene ic
egula ion.
In oduc ion
Diabe ic neph opa hy (DN) is ecognized as one o he mos c i ical mic o ascula
complica ions o diabe es melli us, ep esen ing a leading cause o ch onic kidney disease (CKD)
ISSN:
2181-3906
2025
In e na ional scien i ic jou nal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 11 / UIF:8.2 / MODERNSCIENCE.UZ
724
and end-s age enal disease (ESRD) wo ldwide. O e he pas wo decades, he inc easing global
p e alence o ype 1 and ype 2 diabe es has signi ican ly in ensi ied he bu den o DN, wi h
ecen epidemiological analyses showing ha nea ly 30–40% o all diabe ic pa ien s e en ually
de elop measu able signs o enal impai men [1].
Al hough imp o emen s in glycemic con ol and an ihype ensi e he apy ha e educed
he incidence o some diabe ic complica ions, DN con inues o ise s eadily, d i en by aging
popula ions, seden a y li es yles, and he g owing epidemic o obesi y and me abolic synd ome
[2]. F om a pa hophysiological s andpoin , DN is no a single-pa hway diso de bu a he he
culmina ion o complex and in e connec ed biochemical and molecula p ocesses. Pe sis en
hype glycemia igge s a cascade o me abolic abno mali ies ha dis up cellula homeos asis in
glome ula , ubula , and endo helial s uc u es.
Among he ea lies e en s is excessi e lux h ough al e na i e biochemical pa hways,
including he polyol pa hway, he hexosamine biosyn he ic pa hway, and he o ma ion o
ad anced glyca ion end p oduc s (AGEs). These me abolic dis u bances ac i a e in acellula
signaling cascades—mos no ably he p o ein kinase C (PKC) pa hway—which al e ascula
pe meabili y, impai endo helial ni ic oxide p oduc ion, and s imula e p o-in lamma o y and
p o ib o ic gene exp ession [3][4]. Concu en ly, oxida i e s ess eme ges as a cen al
mechanism in DN pa hogenesis. Hype glycemia-induced o e p oduc ion o eac i e oxygen
species (ROS), p ima ily om dys unc ional mi ochond ia and NADPH oxidase complexes,
o e whelms he an ioxidan de ense sys em. ROS accumula ion damages lipids, p o eins, and
DNA, ul ima ely dis up ing glome ula il a ion ba ie in eg i y. Podocy es—highly specialized
epi helial cells essen ial o main aining il a ion selec i i y—a e pa icula ly ulne able.
Podocy e oo p ocess e acemen , apop osis, and de achmen om he glome ula basemen
memb ane ep esen ea ly i e e sible e en s ha d i e p og essi e albuminu ia, one o he
clinical hallma ks o DN [5]. In lamma ion u he ampli ies enal inju y. Hype glycemia
p omo es ac i a ion o NF-κB and o he ansc ip ion ac o s ha up egula e he exp ession o
p o-in lamma o y cy okines such as TNF-α, IL-1β, IL-6, and MCP-1. These media o s ec ui
mac ophages and monocy es o enal issues, es ablishing a ch onic in lamma o y s a e ha
accele a es mesangial expansion, endo helial dys unc ion, and ex acellula ma ix accumula ion.
O e ime, pe sis en in lamma ion ac i a es ib o ic pa hways, including TGF-β/Smad
signaling, culmina ing in glome uloscle osis and in e s i ial ib osis—pa hological changes ha
co ela e s ongly wi h long- e m enal decline [6][7]. Hemodynamic al e a ions also play an
indispensable ole. Diabe ic pa ien s o en de elop hype il a ion du ing ea ly disease s ages, a
phenomenon d i en pa ly by inc eased in aglome ula p essu e esul ing om a e en a e iole
dila ion and impai ed au o egula ion.
Dys egula ion o he enin–angio ensin–aldos e one sys em (RAAS) u he con ibu es
o glome ula hype ension, s imula ing cellula hype ophy and ma ix deposi ion wi hin he
glome ula basemen memb ane. Angio ensin II is pa icula ly pa hogenic due o i s combined
asocons ic i e, p o-in lamma o y, and p o- ib o ic ac ions. Long- e m exposu e o angio ensin
II p omo es mesangial expansion and accele a es podocy e loss, pe pe ua ing s uc u al kidney
damage [8]. Recen b eak h oughs ha e highligh ed he impo ance o epigene ic mechanisms in
DN p og ession.
ISSN:
2181-3906
2025
In e na ional scien i ic jou nal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 11 / UIF:8.2 / MODERNSCIENCE.UZ
725
E en a e glycemic con ol is achie ed, many pa ien s con inue o expe ience wo sening
enal unc ion—a phenomenon known as “me abolic memo y.” Epigene ic modi ica ions,
including DNA me hyla ion, his one ace yla ion, and egula ion by mic oRNAs, appea o
p ese e hype glycemia-induced pa hogenic signals wi hin enal cells. These modi ica ions al e
he ansc ip ional landscape and sus ain he ac i a ion o in lamma o y and ib o ic genes long
a e glucose le els no malize. This pa adigm shi has p o ound implica ions o he apeu ic
de elopmen , as a ge ing epigene ic egula o s may help dis up he pe sis en molecula imp in
o diabe es on enal issues [9][10]. Clinically, DN p og esses h ough well-de ined s ages
beginning wi h enal hype il a ion, ollowed by mic oalbuminu ia, mac oalbuminu ia,
declining glome ula il a ion a e (GFR), and ul ima ely ESRD. Ea ly de ec ion is c ucial, ye
challenges emain. Mic oalbuminu ia, once conside ed he p ima y ma ke o ea ly DN, is now
known o be nei he uni o mly p esen no en i ely speci ic; some pa ien s p og ess o educed
GFR wi hou signi ican p o einu ia. This has p omp ed inc eased in e es in no el bioma ke s
such as u ina y NGAL, KIM-1, cys a in C, and ci cula ing in lamma o y molecules ha may
de ec enal inju y ea lie and wi h g ea e p ecision [11]. Despi e subs an ial ad ances in
unde s anding DN biology, e ec i e disease-modi ying ea men s emain limi ed.
Cu en he apeu ic s a egies p ima ily a ge isk ac o s such as hype glycemia,
hype ension, and RAAS ac i a ion. Sodium–glucose co anspo e -2 (SGLT2) inhibi o s and
GLP-1 ecep o agonis s ha e shown p omise in educing DN p og ession by imp o ing
me abolic con ol and exe ing enop o ec i e e ec s h ough hemodynamic and an i-
in lamma o y mechanisms. Howe e , he g owing body o e idence on oxida i e s ess,
in lamma ion, and epigene ic al e a ions unde sco es he need o mul i- a ge he apies capable
o add essing he mul i ac o ial na u e o DN [12] [13]. Gi en he inc easing public heal h
bu den o diabe es and he subs an ial economic impac o CKD managemen , a deepe
unde s anding o DN pa hogenesis is essen ial. This pape he e o e examines he biological
mechanisms con ibu ing o diabe ic neph opa hy, in eg a ing ecen esea ch om 2020 o 2024.
Emphasis is placed on molecula pa hways, in lamma ion, oxida i e s ess, hemodynamic
changes, and epigene ic egula ion, wi h he aim o p o iding a comp ehensi e and upda ed
amewo k o clinicians, esea che s, and s uden s seeking o unde s and his complex and
e ol ing disease p ocess.
Conclusion
Diabe ic neph opa hy (DN) s ands as a complex and mul i ac o ial disease p ocess shaped
by he cumula i e e ec s o me abolic dys egula ion, oxida i e s ess, in lamma ion,
hemodynamic abno mali ies, and epigene ic al e a ions. Al hough hype glycemia is he cen al
ini ia ing ac o , i is he downs eam ne wo k o in e dependen molecula dis up ions ha
ul ima ely d i es enal s uc u al and unc ional decline. The in e play be ween AGEs o ma ion,
PKC pa hway ac i a ion, and mi ochond ial ROS o e p oduc ion ini ia es ea ly cellula inju y in
he glome ulus and enal ubules. These me abolic dis u bances a e u he ampli ied by ch onic
ac i a ion o p o-in lamma o y signaling pa hways, including NF-κB–media ed cy okine
cascades, which p omo e mesangial expansion, endo helial dys unc ion, and ex acellula ma ix
accumula ion. The pe sis en in ol emen o he enin–angio ensin–aldos e one sys em (RAAS)
unde sco es he c i ical ole o glome ula hype ension in accele a ing enal damage.
ISSN:
2181-3906
2025
In e na ional scien i ic jou nal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 11 / UIF:8.2 / MODERNSCIENCE.UZ
726
Angio ensin II–d i en asocons ic ion, in lamma ion, and ib osis con ibu e o
p og essi e podocy e loss and glome uloscle osis, ma king an i e e sible ansi ion owa d
ch onic kidney disease. No ably, he disco e y o epigene ic modi ica ions as key d i e s o
“me abolic memo y” has eshaped unde s anding o DN p og ession, e ealing ha biochemical
and ansc ip ional dis u bances can pe sis e en a e achie ing glycemic con ol. These insigh s
highligh he need o he apeu ic s a egies ha ex end beyond glucose and blood p essu e
managemen o a ge deepe molecula p ocesses esponsible o ch onic enal inju y.
Recen he apeu ic ad ances—including SGLT2 inhibi o s, GLP-1 ecep o agonis s,
no el an i-in lamma o y agen s, and po en ial epigene ic modula o s—o e p omising a enues
o slowing DN p og ession. Howe e , he con inued global ise in diabe es p e alence demands
mo e p ecise bioma ke s o ea ly de ec ion and mo e e ec i e mul i- a ge ea men s ha
add ess he disease’s unde lying biological complexi y. As eme ging esea ch om 2020–2024
con inues o elucida e p e iously un ecognized egula o y pa hways, he p ospec o
pe sonalized, mechanism-based he apy becomes inc easingly a ainable. Ul ima ely, imp o ing
ou comes o pa ien s wi h diabe ic neph opa hy equi es an in eg a ed app oach ha combines
me abolic con ol, enop o ec i e pha maco he apy, li es yle modi ica ion, and a ge ed
in e en ion guided by a deepe unde s anding o he disease’s cellula and molecula
mechanisms. This comp ehensi e pe spec i e p o ides a i al ounda ion o u u e inno a ions
aimed a p e en ing, hal ing, o e en e e sing he p og ession o diabe ic kidney disease.
Re e ences
1. Ame ican Diabe es Associa ion. “Ch onic Kidney Disease and Risk Managemen :
S anda ds o Medical Ca e in Diabe es—2024.” Diabe es Ca e, ol. 47, 2024.
2. Thomas MC, B ownlee M. “The Pa hobiology o Hype glycemia and I s Role in Diabe ic
Complica ions.” Na u e Re iews Endoc inology, 2023.
3. Pichle R, A ka ian M, Die e BP. “In lamma o y Pa hways in Diabe ic Kidney Disease.”
Jou nal o he Ame ican Socie y o Neph ology (JASN), 2022.
4. Kim YG, Lee SH. “Molecula Mechanisms o Diabe ic Neph opa hy: Focus on Oxida i e
S ess and Mi ochond ial Dys unc ion.” Kidney In e na ional Repo s, 2021.
5. Papadopoulou-Ma ke ou N. “Epigene ic Dys egula ion in Diabe ic Neph opa hy.”
F on ie s in Endoc inology, 2022.
6. Kolse h IB, Reinhold H, Jensen T. “Glome ula Hemodynamic Al e a ions in Ea ly
Diabe ic Kidney Disease.” Neph ology Dialysis T ansplan a ion, 2024.
7. B eye MD, Susz ak K. “Mechanisms o Kidney Inju y in Diabe es: Eme ging
Bioma ke s and Molecula Ta ge s.” Na u e Re iews Neph ology, 2021.
8. KDIGO Clinical P ac ice Guideline. “Managemen o Diabe ic Kidney Disease.” Kidney
In e na ional Supplemen s, 2022.
9. Fo bes JM, Tho bu n DR. “Mi ochond ial Dys unc ion in Diabe ic Kidney Disease.” Cell
Me abolism, 2023.
10. Alicic RZ, Rooney MT. “The G owing Global Epidemic o Diabe ic Kidney Disease.”
The Lance Diabe es & Endoc inology, 2020.
ISSN:
2181-3906
2025
In e na ional scien i ic jou nal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 11 / UIF:8.2 / MODERNSCIENCE.UZ
727
11. Ba e a-Chimal J, Jaisse F. “No el The apeu ic Pa hways o Diabe ic Neph opa hy.”
Annual Re iew o Pha macology and Toxicology, 2024.
12. Hee spink HJL, S e ánsson BV. “Renop o ec i e E ec s o SGLT2 Inhibi o s.” New
England Jou nal o Medicine (NEJM), 2021.
13. Bak is GL, Aga wal R. “GLP-1 Recep o Agonis s o Kidney P o ec ion in Type 2
Diabe es.” The Lance , 2023.
